St. Judes ALLR17

A Study of Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase II, Active (2007)

Trial date: begun 2003.

The trial is described on the St Judes and the web sites (links above). The overview provided is less informative than the outlines provided for the COG clinical trials.

Note: St. Jude Children's Research Hospital hosts a semi-restricted site at On registration and approval, one has access to a plethora of seminars. For relapsed ALL, listen to "Relapsed acute lymphoblastic leukemia in childhood", Presenter: Nobuko Hijiya, MD, Dec. 2006. This seminar describes St. Jude's ALL relapse treatment in more detail than the outlines linked to above.